Localization of mRNA for SHIP2, SH2 domain-containing inositol polyphosphate 5-phosphatase, in the brain of developing and mature rats

被引：5

作者：

Kudo, M

Saito, S

Owada, Y

Suzuki, H

Kondo, H

机构：

[1] Tohoku Univ, Grad Sch Med Sci, Dept Cell Biol, Div Histol,Aoba Ku, Sendai, Miyagi 9808575, Japan

[2] Showa Univ, Sch Med, Dept Otolaryngol, Tokyo 1428555, Japan

来源：

MOLECULAR BRAIN RESEARCH | 2000年 / 75卷 / 01期

关键词：

SHIP; brain; rat; in situ hybridization histochemistry;

D O I：

10.1016/S0169-328X(99)00311-3

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

The localization of mRNA for SHIP2, SH2 domain containing inositol 5-phosphatase SHIP isozyme, was examined by in situ hybridization histochemistry in the brain of developing and mature rats; SHIP2 mRNA was first detected in the ventricular germinal zone at embryonic stages. As the postnatal development proceeded, the expression signal was evident in cell of the white matters, presumptive oligodendrocytes, and no significant expression was seen in neurons throughout the development. (C) 2000 Elsevier Science B.V. All rights reserved.

引用

页码：172 / 177

页数：6

共 50 条

[1] The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2
Dyson, JM
Kong, AM
Wiradjaja, F
Astle, MV
Gurung, R
Mitchell, CA
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (11): : 2260 - 2265
[2] Studies on the regulation of SH2 domain-containing inositol 5-phosphatase(SHIP) activity.
Phee, H
Jacob, A
Coggeshall, KM
FASEB JOURNAL, 2000, 14 (06): : A967 - A967
[3] Sh2 Domain-Containing 5-Inositol Phosphatase 2 (SHIP2) is an Effector of Lymphatic Dysfunction
Agollah, Germaine D.
Sevick-Muraca, Eva M.
CIRCULATION, 2013, 128 (22)
[4] SHIP2 (SH2 Domain-containing Inositol Phosphatase 2) SH2 Domain Negatively Controls SHIP2 Monoubiquitination in Response to Epidermal Growth Factor
De Schutter, Julie
Guillabert, Aude
Imbault, Virginie
Degraef, Chantal
Erneux, Christophe
Communi, David
Pirson, Isabelle
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (52) : 36062 - 36076
[5] Evidence for SH2 Domain-Containing 5′-Inositol Phosphatase-2 (SHIP2) Contributing to a Lymphatic Dysfunction
Agollah, Germaine D.
Gonzalez-Garay, Manuel L.
Rasmussen, John C.
Tan, I-Chih
Aldrich, Melissa B.
Darne, Chinmay
Fife, Caroline E.
Guilliod, Renie
Maus, Erik A.
King, Philip D.
Sevick-Muraca, Eva M.
PLOS ONE, 2014, 9 (11):
[6] Regulation of endogenous SH2 domain-containing inositol 5-phosphatase (SHIP2) in 3T3-L1 and human preadipocytes
Gagnon, A
Artemenko, Y
Crapper, T
Sorisky, A
JOURNAL OF CELLULAR PHYSIOLOGY, 2003, 197 (02) : 243 - 250
[7] Aminocholestane and Aminoandrostane Inhibitors of the SH2 Domain-Containing Inositol 5'-Phosphatase (SHIP)
Pacherille, Angela M.
Viernes, Dennis R.
Pedicone, Chiara
Fernandes, Sandra
Dungan, Otto M.
Dormann, Shawn
Wallach, Daniel R.
Sudan, Raki
Brooks, Robbie
Russo, Christopher M.
Howard, Kyle T.
Cosgrove, Michael S.
Kerr, William G.
Chisholm, John D.
CHEMMEDCHEM, 2025,
[8] A high-throughput microfluidic assay for SH2 domain-containing inositol 5-phosphatase 2
Rowe, Todd
Hale, Clarence
Zhou, Aileen
Kurzeja, Robert J. M.
Ali, Arisha
Menjares, Anthony
Wang, Minghan
McCarter, John D.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2006, 4 (02) : 175 - 183
[9] Therapeutic Potential of SH2 Domain-Containing Inositol-5′-Phosphatase 1 (SHIP1) and SHIP2 Inhibition in Cancer
Gwenny M. Fuhler
Robert Brooks
Bonnie Toms
Sonia Iyer
Elizabeth A. Gengo
Mi-Young Park
Matthew Gumbleton
Dennis R. Viernes
John D. Chisholm
William G. Kerr
Molecular Medicine, 2012, 18 : 65 - 75
[10] Therapeutic Potential of SH2 Domain-Containing Inositol-5′-Phosphatase 1 (SHIP1) and SHIP2 Inhibition in Cancer
Fuhler, Gwenny M.
Brooks, Robert
Toms, Bonnie
Iyer, Sonia
Gengo, Elizabeth A.
Park, Mi-Young
Gumbleton, Matthew
Viernes, Dennis R.
Chisholm, John D.
Kerr, William G.
MOLECULAR MEDICINE, 2012, 18 (01) : 65 - 75

← 1 2 3 4 5 →